HighTower Advisors LLC raised its position in shares of Genpact Limited (NYSE:G - Free Report) by 112.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,573 shares of the business services provider's stock after acquiring an additional 6,647 shares during the quarter. HighTower Advisors LLC's holdings in Genpact were worth $540,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. SRH Advisors LLC purchased a new stake in Genpact during the 4th quarter valued at about $26,000. Manchester Capital Management LLC acquired a new position in shares of Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC grew its position in shares of Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp lifted its position in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after buying an additional 453 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have issued reports on G. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho boosted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Needham & Company LLC increased their price target on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $48.44.
Get Our Latest Analysis on Genpact
Genpact Trading Down 0.1 %
NYSE:G traded down $0.03 during trading hours on Wednesday, reaching $50.53. 1,561,085 shares of the stock were exchanged, compared to its average volume of 1,350,328. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The business has a 50-day moving average of $51.13 and a two-hundred day moving average of $45.31. The company has a market capitalization of $8.88 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 1.84 and a beta of 1.06. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.35%. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is 23.94%.
Insider Buying and Selling
In related news, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.